Core Viewpoint - Hongbo Pharmaceutical (301230.SZ) has signed a supplementary agreement to extend the action agreement among its actual controllers until October 31, 2025, reflecting confidence in the company's long-term development and aiming to enhance operational decision-making efficiency [1] Group 1 - The supplementary agreement to the action agreement among Ping Chen, An Rongchang, and Jiang Shengli will expire on October 31, 2025 [1] - The voting rights entrustment relationship between shareholders of Pharma Resources Holding Co., Ltd. and Ping Chen will also expire on October 31, 2025 [1] - The parties involved have signed a new supplementary agreement to extend the action relationship, ensuring the company's stable development [1] Group 2 - Hongjian Zhang and Michael Gao have recently signed revised voting rights entrustment agreements with Ping Chen to extend their voting rights relationship [1] - The voting rights entrustment relationship between Genesis and Ping Chen will not be renewed [1]
泓博医药(301230.SZ)：实际控制人一致行动关系续期及间接控股股东部分上层股东表决权委托续期